ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 16 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,181 | -41.7% | 13,823 | -0.3% | 0.00% | – |
| Q2 2023 | $17,470 | +69.9% | 13,865 | -2.3% | 0.00% | – |
| Q1 2023 | $10,283 | +35.4% | 14,186 | -1.3% | 0.00% | – |
| Q4 2022 | $7,595 | -36.7% | 14,371 | -0.0% | 0.00% | – |
| Q3 2022 | $12,000 | -29.4% | 14,376 | -8.2% | 0.00% | – |
| Q2 2022 | $17,000 | +6.2% | 15,654 | -0.7% | 0.00% | – |
| Q1 2022 | $16,000 | -42.9% | 15,761 | -9.0% | 0.00% | – |
| Q4 2021 | $28,000 | -51.7% | 17,315 | -3.0% | 0.00% | – |
| Q3 2021 | $58,000 | -50.4% | 17,854 | -3.3% | 0.00% | – |
| Q2 2021 | $117,000 | +408.7% | 18,468 | +67.2% | 0.00% | – |
| Q1 2021 | $23,000 | +475.0% | 11,047 | +256.4% | 0.00% | – |
| Q1 2020 | $4,000 | +33.3% | 3,100 | +88.8% | 0.00% | – |
| Q3 2019 | $3,000 | – | 1,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |